Warning letter
Vidco, Inc.: warning letter of May 5, 2017
FDA warning letter 516295 · Seattle District Office
Key facts
| Reference number | 516295 |
|---|---|
| Company | Vidco, Inc. |
| Subject | CGMP/QSR/Medical Devices/Adulterated/Misbranded |
| Issue date | May 5, 2017 |
| Posted date | May 16, 2017 |
| Issuing office | Seattle District Office |
| Product type | Devices |
| CFR sections cited | 803.3, 803.17, 806, 806.10, 803.20(c)(1), 803.50(a)(1), 803.50(a)(2), 806.2(k)(2), 820, 803.50(a), 803.19(b), 803 |
| Inspection city | Beaverton |
| Inspection ZIP | 97008 |
| Inspection start date | Jan 3, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: